Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. - Gavelli, Francesco; Giolitti, Francesca Maria; Vidali, Matteo; Montersino, Marta; Bertoli, Matteo; Molinari, Luca; Baldrighi, Marco; Beltrame, Michela; Sainaghi, Pier Paolo; Bellan, Mattia; Patrucco, Filippo; Avanzi, Gian Carlo; et al. (Diagnostics (2075-4418), 2025)